BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9649208)

  • 1. Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.
    Seo N; Tokura Y; Matsumoto K; Furukawa F; Takigawa M
    Clin Exp Immunol; 1998 Jun; 112(3):403-9. PubMed ID: 9649208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells.
    Vowels BR; Cassin M; Vonderheid EC; Rook AH
    J Invest Dermatol; 1992 Jul; 99(1):90-4. PubMed ID: 1607682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
    Zaki MH; Shane RB; Geng Y; Showe LC; Everetts SE; Presky DH; Wysocka M; Moore JS; Rook AH
    J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.
    Rook AH; Kubin M; Cassin M; Vonderheid EC; Vowels BR; Wolfe JT; Wolf SF; Singh A; Trinchieri G; Lessin SR
    J Immunol; 1995 Feb; 154(3):1491-8. PubMed ID: 7822812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma.
    Rook AH; Kubin M; Fox FE; Niu Z; Cassin M; Vowels BR; Gottleib SL; Vonderheid EC; Lessin SR; Trinchieri G
    Ann N Y Acad Sci; 1996 Oct; 795():310-8. PubMed ID: 8958942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.
    Yoo EK; Cassin M; Lessin SR; Rook AH
    J Am Acad Dermatol; 2001 Aug; 45(2):208-16. PubMed ID: 11464181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sézary syndrome, T-helper 2 cytokines and accessory factor-1 (AF-1).
    Dummer R; Geertsen R; Ludwig E; Niederer E; Burg G
    Leuk Lymphoma; 1998 Feb; 28(5-6):515-22. PubMed ID: 9613981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT; Grant AJ; Siegel JP
    J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12.
    Suchin KR; Cassin M; Gottleib SL; Sood S; Cucchiara AJ; Vonderheid EC; Rook AH
    J Am Acad Dermatol; 2001 Jan; 44(1):28-32. PubMed ID: 11148473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
    Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R
    Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
    Yoon JS; Newton SM; Wysocka M; Troxel AB; Hess SD; Richardson SK; Lin JH; Benoit BM; Kasprzycka M; Wasik MA; Rook AH
    J Invest Dermatol; 2008 Feb; 128(2):473-80. PubMed ID: 17713571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA.
    Ni X; Richmond HM; Liao XM; Decker WK; Shiue LH; Shpall EJ; Duvic M
    J Invest Dermatol; 2008 Nov; 128(11):2631-2639. PubMed ID: 18480841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the functions of dengue virus-specific human CD8+ cytotoxic T cell clone by IL-2, IL-7 and IFN gamma.
    Livingston PG; Toomey S; Kurane I; Janus J; Ennis FA
    Immunol Invest; 1995 May; 24(4):619-29. PubMed ID: 7622198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones.
    Parronchi P; De Carli M; Manetti R; Simonelli C; Sampognaro S; Piccinni MP; Macchia D; Maggi E; Del Prete G; Romagnani S
    J Immunol; 1992 Nov; 149(9):2977-83. PubMed ID: 1401925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD7-positive Sézary syndrome with a Th1 cytokine profile.
    Yagi H; Tokura Y; Furukawa F; Takigawa M
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines.
    Wysocka M; Zaki MH; French LE; Chehimi J; Shapiro M; Everetts SE; McGinnis KS; Montaner L; Rook AH
    Blood; 2002 Nov; 100(9):3287-94. PubMed ID: 12384429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
    J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
    Tendler CL; Burton JD; Jaffe J; Danielpour D; Charley M; McCoy JP; Pittelkow MR; Waldmann TA
    Cancer Res; 1994 Aug; 54(16):4430-5. PubMed ID: 7913876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.